Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice
Author(s) -
Li Ni,
Satadru K. Lahiri,
Jiali Nie,
Xiaolu Pan,
Issam Abu-Taha,
Julia O. Reynolds,
Hannah M. Campbell,
Haihao Wang,
Markus Kamler,
Wilhelm Schmitz,
Frank U. Müller,
Na Li,
Wei Xiang,
Dao Wen Wang,
Dobromir Dobrev,
Xander H.T. Wehrens
Publication year - 2021
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvab325
Subject(s) - nfat , medicine , endocrinology , ryanodine receptor , phospholamban , calsequestrin , ryanodine receptor 2 , genetically modified mouse , biology , knockout mouse , transgene , receptor , calcineurin , heart failure , biochemistry , transplantation , gene
Abnormal intracellular calcium (Ca2+) handling contributes to the progressive nature of atrial fibrillation (AF), the most common sustained cardiac arrhythmia. Evidence in mouse models suggests that activation of the nuclear factor of activated T-cell (NFAT) signalling pathway contributes to atrial remodelling. Our aim was to determine the role of NFATc2 in AF in humans and mouse models.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom